DCGI approves anti-COVID drug developed by DRDO
HYDERABAD: The Institute of Nuclear Medicine and Allied Sciences, a lab in DRDO along with Dr Reddy's Laboratories developed an anti-Corona therapeutic application of the drug 2-DG (2-deoxy D glucose. Drugs Controller General of India’s (DCGI) gave emergency usage permission for the drug.
The third phase of the clinical trials showed that the drug effectively fighting against the Coronavirus. It helps the hospitalised patients to recover faster and reduces the dependency on oxygen. The 2-DG was used in treating COVID patients who tested negative in RT-PCR tests after use. Click the video for more details.